Available in your choice of English or Arabic
Memphis Pharma has a new CEO: The drug manufacturer appointed board member Tarek Mahrous Salman as acting CEO after its board approved the resignation of Bassem Abdallah (LinkedIn), according to an EGX disclosure (pdf).
Israel’s Arkia shifts some flights to Egypt as airspace tightens…
Plus: Incolease taps securitization market with debut EGP 2 bn…
PE and VC-backed companies were already pivoting to local exchanges…
Telda claims users can sell a position and immediately spend…
Queue
Egypt Edition 
UAE Edition 
Saudi Edition 
MENA <> India Corridors 
Logistics (MENA) 
Climate (MENA) 
Share
Read Full Issue